These Ras effectors also interact preferentially with GTP-bound Ras [41], but while it is clear that Raf-independent Ras-driven transformation contributes to tumorigenesis [42], the Ras-Raf-MEK-ERK cascade is still a very enticing area for cancer therapeutic development. The gene discussed is RAF1; the disease is cancer.